These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9660604)

  • 21. False-negative rate of cervical cytology: sense and sensitivity.
    Giard RW
    Diagn Cytopathol; 2001 Nov; 25(5):275-7. PubMed ID: 11747215
    [No Abstract]   [Full Text] [Related]  

  • 22. From the Centers for Disease Control. Cervical cancer control--Rhode Island.
    JAMA; 1989 Oct; 262(15):2075-6. PubMed ID: 2795777
    [No Abstract]   [Full Text] [Related]  

  • 23. Milwaukee deaths reignite critical issues in cervical cancer screening.
    Voelker R
    JAMA; 1995 May 24-31; 273(20):1559-60. PubMed ID: 7745755
    [No Abstract]   [Full Text] [Related]  

  • 24. Improvement in the routine screening of cervical smears: A study using rapid prescreening and 100% rapid review as internal quality control methods.
    Tavares SB; Alves de Sousa NL; Manrique EJ; Pinheiro de Albuquerque ZB; Zeferino LC; Amaral RG
    Cancer Cytopathol; 2011 Dec; 119(6):367-76. PubMed ID: 21954191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How preventable is invasive cervical cancer? A community study of preventable factors.
    Martin PL
    Trans Pac Coast Obstet Gynecol Soc; 1971; 39(0):114-21. PubMed ID: 5164820
    [No Abstract]   [Full Text] [Related]  

  • 26. [Screening for carcinoma of the cervix today].
    Calzolari E; Ciampaglia G; Coppola S
    Minerva Ginecol; 1996 Nov; 48(11):453-61. PubMed ID: 9005371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Consequences of incorrect interpretation of vaginal smear tests in a screening program].
    Lynge E; Arffmann E; Poll P; Andersen PK
    Ugeskr Laeger; 1994 Apr; 156(17):2594-6. PubMed ID: 8016968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gynecological cytodiagnosis with screening (a solution from necessity)].
    Janisch H; Kremer H
    Zentralbl Gynakol; 1969 Nov; 91(45):1488-90. PubMed ID: 5376960
    [No Abstract]   [Full Text] [Related]  

  • 29. Rapid pre-screening of Pap smears in quality control: an Italian experience.
    Placidi A; Manca G; Mania E; Arbyn M
    Cytopathology; 2004 Apr; 15(2):121-3. PubMed ID: 15056176
    [No Abstract]   [Full Text] [Related]  

  • 30. [Present status of mass screening of cancer of the uterine cervix].
    Kutsuzawa T; Moriya S; Okubo H; Sakuragi N; Ichinohe K
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):499-504. PubMed ID: 3758914
    [No Abstract]   [Full Text] [Related]  

  • 31. How preventable is invasive cervical cancer? A community study of preventable factors.
    Martin PL
    Am J Obstet Gynecol; 1972 Jun; 113(4):541-8. PubMed ID: 4636632
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation and costing of mass screening programmes for cervical cancer.
    Neuser D
    Tumori; 1976; 62(3):351-3. PubMed ID: 1014134
    [No Abstract]   [Full Text] [Related]  

  • 33. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
    Linder J; Zahniser D
    Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of repeat cytology at the time of colposcopy for the evaluation of cervical intraepithelial neoplasia on Papanicolaou smears.
    Wheelock JB; Kaminski PF
    J Reprod Med; 1989 Oct; 34(10):815-7. PubMed ID: 2795564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening cervical smears.
    Laming D
    Br J Psychol; 1995 Nov; 86 ( Pt 4)():507-16. PubMed ID: 8542199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cervical smears unsuitable for exclusion of cervical carcinoma].
    Giard RW; Blok P
    Ned Tijdschr Geneeskd; 2000 Jan; 144(2):86-7. PubMed ID: 10674109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Part 1: Screening for cervical cancer.
    Gollober M
    Nurse Pract; 1977; 4(5):20, 24, 31. PubMed ID: 492615
    [No Abstract]   [Full Text] [Related]  

  • 38. Automated cervical cytology screening--a gilded or gelded Trojan horse?
    du Toit GC
    S Afr Med J; 1996 Sep; 86(9):1138-40. PubMed ID: 8888795
    [No Abstract]   [Full Text] [Related]  

  • 39. [Formalized malignancy criteria for cytologic screening studies of vaginal smears].
    Vishnevskaia TM; Sitnik AS; Tutina MA
    Lab Delo; 1985; (6):349-51. PubMed ID: 2413256
    [No Abstract]   [Full Text] [Related]  

  • 40. [Analysis of the intralaboratory diagnostic variability in the Imola cervical screening program].
    Fabbris E; Bucchi L; Folicaldi S; Amadori A; Ghidoni D; Medri M; Bondi A
    Pathologica; 1998 Apr; 90(2):127-32. PubMed ID: 9619055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.